Getein Biotech Inc (603387) — Capital Reinvestment Ratio
Getein Biotech Inc (603387) has a Capital Reinvestment Ratio of 0.34x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥100.90 Million) in capital expenditures (CN¥34.34 Million). Check 603387 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Getein Biotech Inc Capital Reinvestment Ratio (2012–2025)
This chart tracks Getein Biotech Inc's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see Getein Biotech Inc cash flow conversion.
Annual Capital Reinvestment Ratio for Getein Biotech Inc (2012–2025)
Year-by-year Capital Reinvestment Ratio for Getein Biotech Inc from 2012 to 2025. See free cash flow generation of Getein Biotech Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | CN¥392.59 Million | CN¥150.58 Million | ▲ +3.7% |
| 2024 | 0.37x | CN¥423.00 Million | CN¥156.40 Million | ▼ -52.3% |
| 2023 | 0.77x | CN¥333.22 Million | CN¥258.13 Million | ▲ +72.1% |
| 2022 | 0.45x | CN¥482.96 Million | CN¥217.44 Million | ▲ +8.4% |
| 2021 | 0.42x | CN¥432.36 Million | CN¥179.60 Million | ▼ -32.1% |
| 2020 | 0.61x | CN¥185.47 Million | CN¥113.53 Million | ▲ +10.7% |
| 2019 | 0.55x | CN¥225.73 Million | CN¥124.82 Million | ▼ -6.6% |
| 2018 | 0.59x | CN¥187.10 Million | CN¥110.74 Million | ▲ +85.2% |
| 2017 | 0.32x | CN¥191.91 Million | CN¥61.35 Million | ▲ +26.8% |
| 2016 | 0.25x | CN¥155.91 Million | CN¥39.31 Million | ▼ -34.2% |
| 2015 | 0.38x | CN¥121.73 Million | CN¥46.65 Million | ▼ -46.1% |
| 2014 | 0.71x | CN¥98.53 Million | CN¥70.09 Million | ▲ +253.3% |
| 2013 | 0.20x | CN¥59.72 Million | CN¥12.02 Million | ▼ -53.9% |
| 2012 | 0.44x | CN¥23.80 Million | CN¥10.39 Million | — |